CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The SFERA project aims to develop a fast internal engraving and reading system for anti-counterfeiting in the pharmaceutical industry. By enhancing existing engraving technology, the project seeks to provide a reliable track and trace solution to combat counterfeit drugs.
The goal of the SFERA project is to deliver a complete innovative solution by developing a new Subsurface, Fast internal Engraving and Reading system suitable for Anticounterfeiting applications needed by the pharmaceutical industry.
Counterfeiting is a major global problem, with important societal and economic consequences, including the expansion of organised crime, loss of jobs and tax revenues, as well as serious health and safety risks, for which the pharmaceutical sector is particularly vu…
AMPLITUDE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Belgium, Liege
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
United Kingdom, LONDON
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Italy, CARPI MO
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
France, EPONE
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
